0001144204-13-000559.txt : 20130103
0001144204-13-000559.hdr.sgml : 20130103
20130103183530
ACCESSION NUMBER: 0001144204-13-000559
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130102
FILED AS OF DATE: 20130103
DATE AS OF CHANGE: 20130103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Snyder Scott A.
CENTRAL INDEX KEY: 0001565556
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32715
FILM NUMBER: 13508968
MAIL ADDRESS:
STREET 1: C/O INTERLEUKIN GENETICS, INC.
STREET 2: 135 BEAVER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02452
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTERLEUKIN GENETICS INC
CENTRAL INDEX KEY: 0001037649
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 943123681
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 135 BEAVER ST
CITY: WATHAM
STATE: MA
ZIP: 02452
BUSINESS PHONE: 1-781-398-0700
MAIL ADDRESS:
STREET 1: 135 BEAVER ST
CITY: WATHAM
STATE: MA
ZIP: 02452
FORMER COMPANY:
FORMER CONFORMED NAME: MEDICAL SCIENCE SYSTEMS INC
DATE OF NAME CHANGE: 19971003
4
1
v331378_form4.xml
OWNERSHIP DOCUMENT
X0306
4
2013-01-02
0
0001037649
INTERLEUKIN GENETICS INC
ILIU
0001565556
Snyder Scott A.
C/O INTERLEUKIN GENETICS, INC.
135 BEAVER STREET
WALTHAM
MA
02452
0
1
0
0
Chief Marketing Officer
Stock Option (Right to Buy)
0.29
2013-01-02
4
A
0
200000
0
A
2023-01-02
Common Stock
200000
200000
D
The exercise price of the option is the closing price of the Issuer's common stock on the OTCQB on 01/02/2013, which was the grant date of the option.
The option vests as to 50,000, 66,000 and 84,000 shares on the first, second and third anniversaries of the grant date, respectively.
/s/ Brian P. Keane, Attorney-in-fact
2013-01-03